Sanofi Adds Depth to its Pipeline with US$2.6 B Nurix Collaboration
By Subham Nandi
Pharma Deals Review: Vol 2020 Issue 1 (Table of Contents)
Published: 28 Jan-2020
DOI: 10.3833/pdr.v2020.i1.2504 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Building on its R&D reorganisation efforts, Sanofi has signed a multi-year collaboration agreement with Nurix Therapeutics to discover, develop and commercialise a pipeline of targeted protein degradation drugs across multiple therapeutic areas...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS